유방암에서 PTEN 종양 억제인자의 발현과 VEGF 매개성 혈관 생성과의 관계

참고문헌 (29)

1. "Identification of a candidatetumor suppressor gene 3 that ismutated in multiple advanced cancers", 15, pp.356~362 (1997)
2. "Germline mutations of the PTEN genein Cowden disease,and inherited breast and thyroid cancer syndrome.", 16, pp.64~67 (1997)
3. "Loss of chromosomal region 10q23-25 in prostate cancer", 55, pp.4800~4803 (1995)
4. "Point mutation and homozygousdeletion of PTEN", MMAC 1 in primary bladder cancers, 1998, pp.16, 3215~3218
5. "Allelic loss of sequences from the long arm of chromosome10 and replicaton errors in endometrial cancers", 55, pp.1922~1926 (1995)
6. "Differential expression of MMAC", PTENin glioblastoma multiforme Relationship to localization and prognosis, 1999, pp.59, 1820~1824
7. "Distribution of the MMAC1", PTEN gene by deletion or mutationis frequent event in malignant melanoma, 1997, pp.57, 3660~3663
8. "Inactivation of the PTEN", MMAC1, pp.1998, 22[DOI]
9. "PTEN, the tumor suppressorfrom human chromosome 10q23, is a dual-specificity phosphatase.", 94, pp.9052~9057 (1997)
10. "The tumor suppressor, PTEN", MMAC1,dephosphorylates the lipid second messenger, phosphatidylinositol3,4,5-trisphosphate., 1998, pp.273, 13375~13378
11. "PTEN:life as a tumor suppressor", 264, pp.29~41 (2001)
12. "Genetic deletion of the Ptentumor suppressor gene promotes cell motility by activation of Rac1and Cdc42 GTPases", 10, pp.401~404 (2000)
13. "PTEN modulates cell cycle progressionand cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphateand Akt", protein kinase B signaling pathway, 1999, pp.96, 6199~6204
14. "Phosphatidylinositol 3 kinasesignaling mediates angiogenesis and expression of vascular endothelialgrowth factor in endothelial cells", 97, pp.1749~1753 (2000)
15. "MMAC", PTENtumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer, 2002, pp.21, 469~475
16. "Induction of vascularendothelial growth factor by hypoxia is modulated by a phosphatidylinositol3-kinase", Akt signaling pathway in Ha-ras-transformedcells through a hypoxia inducible factor-1 transcriptionalelement, 1997, pp.90, 3322~3331
17. "Pathological prognostic factors in breast cancer .I. The value of histological grade in breast cancer experiencefrom a large study with long-term follow-up", pp.403~10 (1991)
18. "Loss of expression of the PTENgene protein product is associated with poor outcome in breast cancer", 14, pp.672~676 (2001)
19. "Tumorangiogenesis correlates with metastasis in invasive prostate carcinoma", 143, pp.401~409 (1993)
20. "Mutation and expressionanalyses reveal differential subcellular compartmentalizationof PTEN in endocrine pancreatic tumors compared to normal isletcells", 157, pp.1097~1103 (2000)
21. "Increased nuclear phosphatase and tensinhomologue deleted on chromosome 10 is associated with G0-G1 inMCF-7 cells Immunohistochemical evidenceof loss of PTEN expression in primary ductal adenocarcinomas ofthe breast", 155, pp.1253~1660 (1999)
22. "Reduced expression of PTEN correlates with breast cancerprogression", 33, pp.405~409 (2002)
23. "Inactivation of the PTEN tumor suppressor geneis associated with increased angiogenesis in clinically localized prostatecarcinoma", 30, pp.419~424 (1999)
24. "PTEN controls tumor-inducedangiogenesis.", 98, pp.4622~4627 (2001)
25. "Mechanisms underlyingPTEN regulation of vascular endothelial growth factor and angiogenesis", 53, pp.109~117 (2003)
26. "How tumors become angiogenic.", 69, pp.135~174 (1996)
27. "Indepedent associationof angiogenesis index with outcome in prostate cancer", 7, pp.81~88 (2001)
28. "Epidermalgrowth factor stimulates vascular endothelial growth factorproduction by human malignant glioma cells a model of glioblastomamultiforme pathophysiology,", 4, pp.121~133 (1993)
29. "Mutant epidermal growthfactor receptor enhances induction of vascular endothelial growthfactor by hypoxia and insulin-like growth factor-1 via a PI3 kinasedependent pathway", 84, pp.1322~1329 (2000)

관련 논문AI추천